Congratulations! Dr. Mohsen Sadatsafavi and Dr. Lindsay Hedden receive MSFHR awards

Recently, the Michael Smith Foundation for Health Research (MSFHR) recognized the work of two C2E2 researchers, Dr. Mohsen Sadatsafavi and Dr. Lindsay Hedden.

C2E2's Nick Bansback and Asif Khowaja award winners at CADTH Conference

Nick Bansback (pictured, second from right)
The Centre for Clinical Epidemiology and Evaluation is pleased to announce that Dr. Nick Bansback has been selected by CADTH as the 2016 recipient of the Maurice McGregor Award, an award that recognizes rising stars in the field of health technology assessment early in their careers.

New project shines spotlight on rare diseases

It’s fitting that this year’s Rare Disease Day falls on a day that only comes around every four years. This leap day, Feb. 29, UBC researchers will launch a project to raise awareness about rare diseases and the issues facing patients and policy makers here in Canada.

Vancouver Stroke Study to use Hyperbaric Chamber

VGH seeking stroke survivors for North America’s first of its kind hyperbaric oxygen study

A multidisciplinary team at Vancouver General Hospital (VGH) will be the first in North America to study the role that hyperbaric oxygen therapy could play in improving neurological function in recovering stroke patients. The group includes scientists Craig Mitton and Penny Brasher from C2E2 and associate scientist, Riyad Abu-Laban.

Boundary-spanning in academic healthcare organisations

C2E2's Post-doctoral fellow, Bryn Lander, has had her article "Boundary-spanning in Academic Healthcare Organizations" published in the journal Research Policy

Common anti-depressant linked to health risk during childbirth

Women taking a common type of antidepressant drug face a significantly higher risk of excessive bleeding after giving birth, according to research by the UBC Faculty of Medicine.

Using health records of women who gave birth in British Columbia between 2002 and 2011, the researchers found that use of selective serotonin-norepinephrine reuptake inhibitors (SNRIs) in the last month of pregnancy increased the likelihood of postpartum hemorrhage by 1.6 times, compared to those not taking SNRIs. Postpartum hemorrhage is a major cause of complications during childbirth.

Patients’ voices are made to matter through shared decision-making

Bridging the knowledge gap, study finds physicians supportive of including patients to guide their own care.